Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Chr. Hansen Holding A/S
  6. Summary
    CHR   DK0060227585

CHR. HANSEN HOLDING A/S

(CHR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
562.6(c) 560.8(c) 571.4(c) 569.2(c) 574.2 Last
220 994 139 441 162 314 228 666 372 020 Volume
+0.90% -0.32% +1.89% -0.39% +0.88% Change
More quotes
Financials
Sales 2021 1 075 M 1 280 M 1 280 M
Net income 2021 868 M 1 033 M 1 033 M
Net Debt 2021 812 M 966 M 966 M
P/E ratio 2021 11,6x
Yield 2021 2,36%
Sales 2022 1 155 M 1 374 M 1 374 M
Net income 2022 244 M 291 M 291 M
Net Debt 2022 776 M 924 M 924 M
P/E ratio 2022 41,3x
Yield 2022 1,24%
Capitalization 10 074 M 12 021 M 11 989 M
EV / Sales 2021 10,1x
EV / Sales 2022 9,40x
Nbr of Employees 3 286
Free-Float 77,9%
More Financials
Company
Chr Hansen Holding A/S is a Denmark-based bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The CompanyÔÇÖs business is divided into three divisions, namely Food Cultures & Enzymes, Health & Nutrition and Natural Colors. The Food Cultures & Enzymes division develops and produces cultures, enzymes and probiotics for the food industry... 
Sector
Food Processing
Calendar
07/08Earnings Release
More about the company
Ratings of Chr. Hansen Holding A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about CHR. HANSEN HOLDING A/S
05/31CHR HANSEN A/Sá : . Hansen JV With Lonza Obtains Manufacturing License In Denmar..
MT
05/31CHR HANSEN A/Sá : Bacthera receives manufacturing licenses in Switzerland and De..
PU
05/31CHR HANSEN A/Sá : . Hansen launches global science-based online platform on prob..
PU
05/18CHR. HANSEN HOLDING A/S : Infrequent or one-off capital gain payment
FA
05/17CHR HANSEN A/Sá : Extraordinary dividend
AQ
05/12CHR HANSEN A/Sá : . Hansen and Nestlé settle court case about Human Milk Oligosa..
PU
05/11CHR HANSEN A/Sá : Sustainability roadshow presentation (May 2021)
PU
05/11CHR HANSEN A/Sá : . Hansen launches VEGA™ Culture Kit specifically develop..
PU
04/28CHR HANSEN A/Sá : . Hansen launches the next generation of FreshQ« food cultures..
PU
04/28CHR HANSEN A/Sá : . Hansen launches the next generation of FreshQ« food cultures..
PU
04/22NEW STUDY : Probiotics may offer immune balancing benefits while improving sleep..
PU
04/16CHR HANSEN A/Sá : Q2 Conference call transcript 2020/21
PU
04/15CHR HANSEN A/Sá : . Hansen Fiscal Q2 Profit Slips 10% Amid Higher Expenses
MT
04/15CHR. HANSEN CONTINUES STRONG MOMENTU : 10% organic growth in Q2
PU
04/15CHR. HANSEN HOLDING A/Sá : Interim report Q2 2020/21
AQ
More news
News in other languages on CHR. HANSEN HOLDING A/S
04/15STOCK MARKET PARIS : Des entreprises gonflées à bloc
04/15EN DIRECT DES MARCHESá : Publicis, Crédit Agricole, Dell, Thermo Fisher, ABB, TS..
01/14CHR. HANSENá : perspectives prudentes pour le reste de l'année
01/14EN DIRECT DES MARCHESá : Renault, Peugeot, Carrefour, Marie Brizard, Intel, Baid..
2020L'indice à suivre pour changer du Nasdaq
More news
Analyst Recommendations on CHR. HANSEN HOLDING A/S
More recommendations
Chart CHR. HANSEN HOLDING A/S
Duration : Period :
Chr. Hansen Holding A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHR. HANSEN HOLDING A/S
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 75,74 €
Last Close Price 76,47 €
Spread / Highest target 14,3%
Spread / Average Target -0,95%
Spread / Lowest Target -13,9%
EPS Revisions
Managers and Directors
NameTitle
Mauricio Graber President & Chief Executive Officer
Lise Skaarup Mortensen Chief Financial Officer & Executive Vice President
Dominique Reiniche Chairman
Thomas Schńfer Chief Scientific Officer & Executive VP
Winnie Hojvang BŘgel VP-Compliance & Corporate Communications
Sector and Competitors